Your browser doesn't support javascript.
loading
Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study.
Flowers, Christopher R; Matasar, Matthew J; Herrera, Alex F; Hertzberg, Mark; Assouline, Sarit; Demeter, Judit; McMillan, Andrew; Mehta, Amitkumar; Opat, Stephen; Trnnný, Marek; Musick, Lisa; Hirata, Jamie; Yang, Annie; Sehn, Laurie H.
Affiliation
  • Flowers CR; Winship Cancer Institute of Emory University, Atlanta, GA. CRFlowers@mdanderson.org.
  • Matasar MJ; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Herrera AF; City of Hope Medical Centre, Duarte, CA.
  • Hertzberg M; Prince of Wales Hospital and University of NSW, Sydney.
  • Assouline S; Jewish General Hospital, Montreal, QC.
  • Demeter J; Semmelweiss University, Budapest, Hungary.
  • McMillan A; Center for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham.
  • Mehta A; University of Alabama at Birmingham, Birmingham.
  • Opat S; Clinical Haematology, Monash Health and Monash University, Clayton.
  • Trnnný M; Charles University General Hospital, Prague, Czech Republic.
  • Musick L; Genentech, Inc., South San Francisco, CA.
  • Hirata J; Genentech, Inc., South San Francisco, CA.
  • Yang A; Genentech, Inc., South San Francisco, CA.
  • Sehn LH; BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC.
Haematologica ; 109(4): 1194-1205, 2024 Apr 01.
Article de En | MEDLINE | ID: mdl-37767550

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome folliculaire / Lymphome B diffus à grandes cellules / Immunoconjugués / Anticorps monoclonaux humanisés / Anticorps monoclonaux Type d'étude: Clinical_trials Limites: Humans Langue: En Journal: Haematologica Année: 2024 Type de document: Article Pays d'affiliation: Gabon

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome folliculaire / Lymphome B diffus à grandes cellules / Immunoconjugués / Anticorps monoclonaux humanisés / Anticorps monoclonaux Type d'étude: Clinical_trials Limites: Humans Langue: En Journal: Haematologica Année: 2024 Type de document: Article Pays d'affiliation: Gabon